ARA-290 (19mg) NEW resulting in visibly improved firmness

resulting in visibly improved firmness

and interaction networks among neuroactive small molecules and peptide pathways

with compound identity confirmed by mass spectrometry

triggering a potent GH release while minimizing cortisol and prolactin-related side effects

ARA-290 (19mg) NEW resulting in visibly improved firmnessComposition and format ARA 290 (19 mg) is a synthetic peptide supplied as a lyophilized powder in a single vial. Each vial contains 19 mg of ARA 290. The batch specific Certificate of Analysis (COA) provides peptide sequence confirmation, molecular weight verification, and formulation details to support method level reproducibility and documentation control in research environments. Analytical verification Each lot is qualified at 99%+ purity by high